Epigenetic and Immune Profile Characteristics in Sinonasal Undifferentiated Carcinoma

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hyang Joo Ryu, Chung Lee, Sun Och Yoon
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Cancer Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Monotherapy With Immune Checkpoint Inhibitors in Patients With Recurrent and/or Metastatic Sinonasal Squamous Cell Carcinoma
by: Alexander Lein, et al.
Published: (2025)

Exploring the Potential of Enhanced Prognostic Performance of NCCN‐IPI in Diffuse Large B‐Cell Lymphoma by Integrating Tumor Microenvironment Markers: Stromal FOXC1 and Tumor pERK1/2 Expression
by: Ji‐Ye Kim, et al.
Published: (2024)

The Survival Benefits of Chemotherapy for Undifferentiated Carcinoma With Osteoclast‐Like Giant Cells of Pancreas: A Retrospective Analysis and Individual Participant Data Meta‐Analysis
by: Ouyang Yonghao, et al.
Published: (2025)

Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis
by: Zhu‐tao Wang, et al.
Published: (2024)

A Retrospective Study on the Clinicopathological Characteristics and Prognostic Analysis of Gynecologic Neuroendocrine Carcinoma
by: Yedan Ren, et al.
Published: (2025)

Correction to “Highly Expressed Carbohydrate Sulfotransferase 11 Correlates With Unfavorable Prognosis and Immune Evasion of Hepatocellular Carcinoma”
Published: (2025)

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
by: Omar Alhalabi, et al.
Published: (2025)

LILRB1 Is a Prognostic‐Related Biomarker Correlated With Immune Infiltration in Head–Neck Squamous Cell Carcinoma
by: Shuai Chen, et al.
Published: (2026)

Correction to “Bioinformatics Identification of Lactate‐Associated Genes in Hepatocellular Carcinoma: G6PD 's Role in Immune Modulation”
Published: (2025)

KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma
by: Yoshinori Nakano, et al.
Published: (2026)

Clinical Characteristics, Treatment and Prognosis of Primary Tracheal Adenoid Cystic Carcinoma: A Multicenter Retrospective Study
by: Yi Luo, et al.
Published: (2025)

Clinical Characteristics of Patients With Advanced Hepatocellular Carcinoma Who Transitioned to Subsequent Therapies Following Systemic Therapy
by: Kenji Imai, et al.
Published: (2026)

Immune Cell Profiling Reveals a Common Pattern in Premetastatic Niche Formation Across Various Cancer Types
by: Shigeaki Sugiyama, et al.
Published: (2024)

Epigenetic Ageing and Breast Cancer Risk: A Systematic Review
by: Emily McLennan, et al.
Published: (2024)

Integrative Analysis Reveals the Prognostic Effects of Epigenetic Regulators in Bladder Cancer
by: Venugopalareddy Mekala, et al.
Published: (2025)

Clinical Characteristics, Gene Mutation Profiles and Prognosis of Patients With Acute Myeloid Leukemia Carrying PHF6 Mutations
by: Dongmei Wang, et al.
Published: (2026)

Leveraging Artificial Intelligence and Radiomics for Improved Nasopharyngeal Carcinoma Prognostication
by: Nicholas Brian Shannon, et al.
Published: (2025)

Efficacy of Neoadjuvant Immunochemotherapy in Pulmonary Lymphoepithelioma Carcinoma Compared With Lung Squamous Cell Carcinoma and Adenocarcinoma: A Retrospective Cohort Study
by: Weizhen Sun, et al.
Published: (2026)

The Treatment of Primary Lymphoepithelioma‐Like Carcinoma in the Head and Neck and Nasopharyngeal Carcinoma
by: Qiaohong Lin, et al.
Published: (2024)

Current Knowledge of Immune Checkpoint Inhibitor‐Induced Thrombocytopenia: Epidemiology, Mechanisms, and Management
by: Youran Dai, et al.
Published: (2026)

Integrated Analysis of Single‐Cell and Bulk RNA‐Sequencing Defines N7‐Methylguanosine (m7G)‐Mediated Modifications' Role in Prognosis and the Tumor Immune Microenvironment in Hepatocellular Carcinoma
by: Jiahua Liang, et al.
Published: (2025)

Correction to “The Treatment of Primary Lymphoepithelioma‐Like Carcinoma in the Head and Neck and Nasopharyngeal Carcinoma”
Published: (2025)

Identification and Validation of Serum Biomarkers to Improve Colorectal Cancer Diagnosis
by: Minha Lea Yoon, et al.
Published: (2024)

Immune‐dysregulation harnessing in myeloid neoplasms
by: Mohammad Jafar Sharifi, et al.
Published: (2024)

CXCL16 Producing Tumor Clones Are Shaping Immunosuppressive Microenvironment in Squamous Cell Carcinoma via CXCR6 Regulatory T Cell
by: Hyun Seung Choi, et al.
Published: (2025)

Combination of LowDose Epigenetic Modifiers and TIC10 for the Activation of Antitumor Immunity and Inhibition of Tumor Growth in Gastrointestinal Cancer
by: Jianling Zou, et al.
Published: (2025)

Characterization of the Pancreatic Neuroendocrine Neoplasm Immune Microenvironment
by: Filipe Reis Neves, et al.
Published: (2025)

Intravital Imaging of Immune Responses in the Cancer Microenvironment
by: Hiroki Hirao, et al.
Published: (2025)

Organ‐Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study
by: Jung Sun Kim, et al.
Published: (2025)

Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China
by: Siming Li, et al.
Published: (2024)

A Butyrate Metabolism‐Related Gene Signature Predicts Prognosis, Immune Landscape, and Immunotherapy Efficacy in Breast Cancer
by: Xu Wang, et al.
Published: (2026)

Immune‐Related Adverse Events in Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors: Insights From a FAERS Disproportionality Analysis
by: Pooja Gokhale, et al.
Published: (2026)

The Immune Landscape of Acral Melanoma: From Basic to Clinical
by: Lihong Jiang, et al.
Published: (2026)

Concomitant Usage of H1‐Antihistamines and Immune Checkpoint Inhibitors on Cancer Patient Survival
by: Yin Leung, et al.
Published: (2025)

Machine Learning‐Based Model for Predicting Recurrence‐Free Survival After Interventional Therapy in Malnourished Hepatocellular Carcinoma Patients
by: Ningning Lu, et al.
Published: (2025)

A Real‐World Experience of Prognostic Factors of Survival Outcomes in a Taiwanese Population With Unresectable Hepatocellular Carcinoma Treated With First‐Line Lenvatinib
by: Shou‐Wu Lee, et al.
Published: (2026)

An Overview of In Vitro Models of Alcohol‐Related Hepatocellular Carcinoma
by: Anoïsia Courtois, et al.
Published: (2025)

The Combined Prognostic Value of 18F‐FDG PET/CT Metabolic Parameters of Immune Organs and Hematological Immune‐Related Markers in Patients With Locally Advanced Cervical Cancer
by: Yi Li, et al.
Published: (2025)

Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study
by: Chengxiang Guo, et al.
Published: (2025)

Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors
by: Young Kwang Chae, et al.
Published: (2025)